Question 1

What are the most cited papers from Apocare Pharma (Germany)?

Accepted Answer

The most cited paper from Apocare Pharma (Germany) is "Does Zinc Supplementation Enhance the Clinical Efficacy of Chloroquine/Hydroxychloroquine to Win Todays Battle Against COVID-19?" (Martin Scholz, Roland Derwand, 2020), with 78 citations. Next come "Photodynamic inactivation of multidrug-resistant Staphylococcus aureus by chlorin e6 and red light (λ = 670 nm)" (54) and "Renal effects of ularitide in patients with decompensated heart failure" (53).

Question 2

Which research topics does Apocare Pharma (Germany) publish most on?

Accepted Answer

By volume in 2022-now: Protein Degradation and Inhibitors, Molecular Biology Techniques and Applications, Chronic Lymphocytic Leukemia Research and Lymphoma Diagnosis and Treatment.

Question 3

Which keywords describe research at Apocare Pharma (Germany)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Reactive Oxygen Species, Photodynamic Therapy, Nanoparticles, Cancer Treatment, Antimicrobial, Drug Discovery, Photosensitizers and Singlet Oxygen.

Question 4

Which fields of science does Apocare Pharma (Germany) work in?

Accepted Answer

In all years, 52% of research at Apocare Pharma (Germany) is in Health Sciences, 33% in Life Sciences. Its largest fields are Medicine (49%), Biochemistry, Genetics and Molecular Biology (24%), Engineering (6%). It does 1.8× the world's share of Health Sciences.

Question 5

Is Apocare Pharma (Germany)'s research output growing?

Accepted Answer

Output in 2022-2025 was 117% higher than in 2018-2021.